Market Closed -
Other stock markets
|
After market 06:07:21 pm | |||
160.4 USD | -1.29% | 161.4 | +0.62% |
May. 08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
May. 08 | Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.54% | 283B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+15.94% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B | |
-1.81% | 160B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03